Novo Nordisk initiates share buyback scheme and acquires shares from owner

The Danish pharmaceutical giant has started a share buyback program and bought DKK 3.4bn (USD 480m) in shares from its owner, Novo Holdings.
Photo: Novo Nordisk / PR
Photo: Novo Nordisk / PR
by marketwire, translated by catherine brett

As part of its DKK 24bn (USD 3.4bn) share buyback plan for 2022, Novo Nordisk started the process of acquiring DKK 4.4bn (USD 620m) of its own shares on Wednesday.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading